vs
Side-by-side financial comparison of UNIVERSAL DISPLAY CORP \PA\ (OLED) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $142.2M, roughly 1.0× UNIVERSAL DISPLAY CORP \PA\). UNIVERSAL DISPLAY CORP \PA\ runs the higher net margin — 25.2% vs -21.1%, a 46.3% gap on every dollar of revenue. On growth, UNIVERSAL DISPLAY CORP \PA\ posted the faster year-over-year revenue change (-14.5% vs -19.2%). Over the past eight quarters, UNIVERSAL DISPLAY CORP \PA\'s revenue compounded faster (-5.3% CAGR vs -7.5%).
Universal Display Corporation is a developer and manufacturer of organic light emitting diode (OLED) technologies and materials, and it is a provider of services to the display and lighting industries.
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
OLED vs OPK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $142.2M | $148.5M |
| Net Profit | $35.9M | $-31.3M |
| Gross Margin | 74.6% | 43.1% |
| Operating Margin | 30.1% | -25.8% |
| Net Margin | 25.2% | -21.1% |
| Revenue YoY | -14.5% | -19.2% |
| Net Profit YoY | -44.3% | -322.8% |
| EPS (diluted) | $0.76 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $142.2M | — | ||
| Q4 25 | $172.9M | $148.5M | ||
| Q3 25 | $139.6M | $151.7M | ||
| Q2 25 | $171.8M | $156.8M | ||
| Q1 25 | $166.3M | $150.0M | ||
| Q4 24 | $162.3M | $183.6M | ||
| Q3 24 | $161.6M | $173.6M | ||
| Q2 24 | $158.5M | $182.2M |
| Q1 26 | $35.9M | — | ||
| Q4 25 | $66.3M | $-31.3M | ||
| Q3 25 | $44.0M | $21.6M | ||
| Q2 25 | $67.3M | $-148.4M | ||
| Q1 25 | $64.4M | $-67.6M | ||
| Q4 24 | $46.0M | $14.0M | ||
| Q3 24 | $66.9M | $24.9M | ||
| Q2 24 | $52.3M | $-10.3M |
| Q1 26 | 74.6% | — | ||
| Q4 25 | 76.1% | 43.1% | ||
| Q3 25 | 74.6% | 32.9% | ||
| Q2 25 | 77.2% | 31.5% | ||
| Q1 25 | 77.1% | 28.4% | ||
| Q4 24 | 77.0% | 46.1% | ||
| Q3 24 | 77.8% | 23.1% | ||
| Q2 24 | 75.8% | 28.4% |
| Q1 26 | 30.1% | — | ||
| Q4 25 | 38.9% | -25.8% | ||
| Q3 25 | 30.9% | 31.7% | ||
| Q2 25 | 39.9% | -38.3% | ||
| Q1 25 | 41.9% | -44.8% | ||
| Q4 24 | 32.3% | -18.0% | ||
| Q3 24 | 41.5% | 8.2% | ||
| Q2 24 | 35.6% | -33.9% |
| Q1 26 | 25.2% | — | ||
| Q4 25 | 38.4% | -21.1% | ||
| Q3 25 | 31.5% | 14.3% | ||
| Q2 25 | 39.2% | -94.7% | ||
| Q1 25 | 38.8% | -45.1% | ||
| Q4 24 | 28.4% | 7.6% | ||
| Q3 24 | 41.4% | 14.3% | ||
| Q2 24 | 33.0% | -5.7% |
| Q1 26 | $0.76 | — | ||
| Q4 25 | $1.40 | $-0.04 | ||
| Q3 25 | $0.92 | $0.03 | ||
| Q2 25 | $1.41 | $-0.19 | ||
| Q1 25 | $1.35 | $-0.10 | ||
| Q4 24 | $0.96 | $0.02 | ||
| Q3 24 | $1.40 | $0.03 | ||
| Q2 24 | $1.10 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $516.4M | $364.4M |
| Total DebtLower is stronger | — | $344.0M |
| Stockholders' EquityBook value | — | $1.3B |
| Total Assets | $1.9B | $1.9B |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $516.4M | — | ||
| Q4 25 | $602.4M | $364.4M | ||
| Q3 25 | $603.0M | $412.0M | ||
| Q2 25 | $525.2M | $267.3M | ||
| Q1 25 | $571.3M | $428.8M | ||
| Q4 24 | $492.7M | $426.6M | ||
| Q3 24 | $551.6M | $400.1M | ||
| Q2 24 | $530.5M | $40.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $344.0M | ||
| Q3 25 | — | $344.2M | ||
| Q2 25 | — | $343.3M | ||
| Q1 25 | — | $439.2M | ||
| Q4 24 | — | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M |
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | $1.7B | $1.3B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B |
| Q1 26 | $1.9B | — | ||
| Q4 25 | $2.0B | $1.9B | ||
| Q3 25 | $1.9B | $2.0B | ||
| Q2 25 | $1.9B | $2.0B | ||
| Q1 25 | $1.9B | $2.1B | ||
| Q4 24 | $1.8B | $2.2B | ||
| Q3 24 | $1.8B | $2.3B | ||
| Q2 24 | $1.8B | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $108.9M | $-25.9M |
| Free Cash FlowOCF − Capex | — | $-28.6M |
| FCF MarginFCF / Revenue | — | -19.3% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | 3.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $108.9M | — | ||
| Q4 25 | $31.1M | $-25.9M | ||
| Q3 25 | $97.2M | $-34.6M | ||
| Q2 25 | $51.9M | $-83.4M | ||
| Q1 25 | $30.6M | $-34.6M | ||
| Q4 24 | $34.7M | $-44.4M | ||
| Q3 24 | $79.9M | $-77.1M | ||
| Q2 24 | $67.0M | $-26.4M |
| Q1 26 | — | — | ||
| Q4 25 | $15.1M | $-28.6M | ||
| Q3 25 | $84.3M | $-37.8M | ||
| Q2 25 | $37.5M | $-86.7M | ||
| Q1 25 | $17.5M | $-37.7M | ||
| Q4 24 | $22.0M | $-49.8M | ||
| Q3 24 | $66.2M | $-85.0M | ||
| Q2 24 | $57.9M | $-33.7M |
| Q1 26 | — | — | ||
| Q4 25 | 8.7% | -19.3% | ||
| Q3 25 | 60.4% | -24.9% | ||
| Q2 25 | 21.8% | -55.3% | ||
| Q1 25 | 10.5% | -25.2% | ||
| Q4 24 | 13.6% | -27.1% | ||
| Q3 24 | 41.0% | -49.0% | ||
| Q2 24 | 36.5% | -18.5% |
| Q1 26 | — | — | ||
| Q4 25 | 9.3% | 1.8% | ||
| Q3 25 | 9.2% | 2.1% | ||
| Q2 25 | 8.4% | 2.1% | ||
| Q1 25 | 7.9% | 2.1% | ||
| Q4 24 | 7.8% | 2.9% | ||
| Q3 24 | 8.4% | 4.6% | ||
| Q2 24 | 5.8% | 4.0% |
| Q1 26 | 3.03× | — | ||
| Q4 25 | 0.47× | — | ||
| Q3 25 | 2.21× | -1.60× | ||
| Q2 25 | 0.77× | — | ||
| Q1 25 | 0.47× | — | ||
| Q4 24 | 0.75× | -3.17× | ||
| Q3 24 | 1.19× | -3.10× | ||
| Q2 24 | 1.28× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLED
| Material sales | $83.7M | 59% |
| Royalty and license fees | $54.2M | 38% |
| Contract research services | $4.3M | 3% |
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
